Literature DB >> 16283420

Anti-cyclic citrullinated peptide antibody in rheumatic diseases other than rheumatoid arthritis.

Toshihiro Matsui, Kota Shimada, Shigeto Tohma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16283420     DOI： 10.1007/s10067-005-0108-y

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  9 in total

1.  Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren's syndrome.

Authors:  J-E Gottenberg; S Mignot; P Nicaise-Rolland; J Cohen-Solal; F Aucouturier; J Goetz; C Labarre; O Meyer; J Sibilia; X Mariette
Journal:  Ann Rheum Dis       Date:  2004-07-01       Impact factor: 19.103

2.  Anti-cyclic citrullinated peptide (anti-CCP) antibodies in children with juvenile idiopathic arthritis.

Authors:  Marion van Rossum; Renée van Soesbergen; Sandra de Kort; Rebecca ten Cate; Aeilko H Zwinderman; Ben de Jong; Ben Dijkmans; Walther J van Venrooij
Journal:  J Rheumatol       Date:  2003-04       Impact factor: 4.666

3.  The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis.

Authors:  E Korendowych; P Owen; J Ravindran; C Carmichael; N McHugh
Journal:  Rheumatology (Oxford)       Date:  2005-05-18       Impact factor: 7.580

4.  The presence of citrullinated proteins is not specific for rheumatoid synovial tissue.

Authors:  Erik R Vossenaar; Tom J M Smeets; Maarten C Kraan; Jos M Raats; Walther J van Venrooij; Paul P Tak
Journal:  Arthritis Rheum       Date:  2004-11

Review 5.  Citrullinated proteins in rheumatoid arthritis.

Authors:  Ryo Yamada; Akari Suzuki; Xiaotian Chang; Kazuhiko Yamamoto
Journal:  Front Biosci       Date:  2005-01-01

6.  Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP).

Authors:  K Forslind; M Ahlmén; K Eberhardt; I Hafström; B Svensson
Journal:  Ann Rheum Dis       Date:  2004-09       Impact factor: 19.103

7.  Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage.

Authors:  O Meyer; C Labarre; M Dougados; Ph Goupille; A Cantagrel; A Dubois; P Nicaise-Roland; J Sibilia; B Combe
Journal:  Ann Rheum Dis       Date:  2003-02       Impact factor: 19.103

8.  High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis.

Authors:  K Suzuki; T Sawada; A Murakami; T Matsui; S Tohma; K Nakazono; M Takemura; Y Takasaki; T Mimori; K Yamamoto
Journal:  Scand J Rheumatol       Date:  2003       Impact factor: 3.641

9.  Diagnostic accuracy of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.

Authors:  O Kasapçopur; S Altun; M Aslan; S Karaarslan; A Kamburoglu-Göksel; S Saribas; N Arisoy; B Kocazeybek
Journal:  Ann Rheum Dis       Date:  2004-12       Impact factor: 19.103
  9 in total
  2 in total

1.  Anti-agalactosyl IgG antibody in ankylosing spondylitis and psoriatic arthritis.

Authors:  Chen-Liang Chou; Min-Jung Wu; Chia-Li Yu; Ming-Chi Lu; Song-Chou Hsieh; Tsai-Hung Wu; Chung-Tei Chou; Chang-Youh Tsai
Journal:  Clin Rheumatol       Date:  2010-03-14       Impact factor: 2.980

2.  Anti-agalactosyl IgG antibodies in Thai patients with rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis.

Authors:  Worawit Louthrenoo; Nuntana Kasitanon; Ramjai Wichainun; Suparaporn Wangkaew; Waraporn Sukitawut; Shoji Kuwata; Fujio Takeuchi
Journal:  Clin Rheumatol       Date:  2009-11-29       Impact factor: 2.980
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.